Rise and shine, another busy day is on the way. And there are no exceptions here on the Pharmalot corporate campus where we are, once again, hustling the short people to their houses of learning. As for us, we have a busy agenda filled with reading interesting materials and meeting interesting people. To prepare, yes, we are downing one or more cups of delicious stimulation. How else to fortify ourselves? Please join us. Meanwhile, here are your tidbits. Have a great day and stay in touch...
Arena Diet Pill Clears DEA Hurdle (Regulatory Focus)
Baxter Alzheimer's Drug Fails In Phase III Trial (MedPage Today)
Lilly CEO To Have Surgery For Dilated Artery (Bloomberg News)
Merck Plays Up Consumer Products In New Campaign (Associated Press)
AbbVie Hep C Combo Receives Breakthrough Designation (Pharma Times)
Docs Don't Test Kids For STDs Or HIV (MedPage Today)
EDITOR'S NOTE: Please check this post for additional stories during the day